Symposiums satellites

×

Message d'avertissement

The subscription service is currently unavailable. Please try again later.

Wednesday July 8, 2015

Symposium presented by ASTRAZENECA

13:45-14:45

Finding the Key to Individualizing Treatment in Type 2 Diabetes
Chairperson: André Carpentier

Objectives
  • Identify appropriate therapeutic targets for T2DM patients with different characteristics
  • Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors
  • Discuss the advantages and disadvantages of the range of antihyperglycemic agents when used as add-on to insulin
  • Distinguish the role of newer pharmacological agents such as GLP-1 agonists, DPP-4 inhibitors and SGLT2 inhibitors as add-on to insulin
13:45-13:55 Introduction André Carpentier
13:55-14:35 Presentation of SGLT2 inhibitors and discussion of different therapeutic choices for a patient on insulin Ronald Goldenberg
14:35-14:45 Questions and discussion  

Wednesday July 8, 2015

Symposium presented by AMGEN CANADA

15:30-17:00

The Challenges of Dyslipidemia Management in Cardiometabolic Disease
Chairperson: Lawrence Leiter

Objectives
  • Review of the current dyslipidemia landscape and evolving research impacting clinical management of cardiometabolic disease
  • Update on the dyslipidemia of diabetes and review of challenges in its management
  • Explain emerging therapies that may impact on the management of dyslipidemia, including the discovery of the role of PCSK9 in LDL-cholesterol metabolism and targeted therapies to block PCSK9 in order to reduce cardiovascular risk
  • Discuss how cardiometabolic disease research in familial hypercholesterolemia is leading to new therapeutic discoveries and treatment options for patients
15:30-15:50
Challenge of dyslipidemia in patients with diabetes
Lawrence Leiter
15:50-16:20
Pathways to emerging therapies
Philip Barter
16:20-16:40
Familial hypercholesterolemia and new therapeutic discoveries
Daniel Gaudet
16:40-17:00
Panel discussion
Faculty

Wednesday July 8, 2015

Symposium presented by INTERNATIONAL MEDICAL PRESS AND INSTITUTE FOR MEDICAL AND NURSING EDUCATION

17:15-18:45

Pharmacotherapy and Weight Control: Why, What and When?
Chairperson: Jean-Pierre Després

Objectives
  • Consider presence of other conditions when implementing weight management strategies
  • Implement strategies to counter weight regain and promote long-term weight control
17:15-17:20 Introduction Jean-Pierre Després
17:20-17:40 Impact of weight loss on cardiometabolic risk  Paul Poirier
17:40-18:00 Tailored approaches to weight control. Is all weight loss the same? Luc Van Gaal
18:00-18:20 Pharmacotherapy, weight loss and fat depots Lawrence Leiter
18:20-18:45 Integrating weight control into the overall management of cardiometabolic risk Interactive discussion

This CME-accredited symposium is supported by an educational grant from Novo Nordisk A/S

Friday July 10, 2015

Symposium presented by YINI and DANONE INSTITUTE OF CANADA

15:30-16:40

Yogurt and Type 2 Diabetes: Overview of the Evidence
Chairpersons: Angelo Tremblay/André Marette

15:30-15:35 Introduction Angelo Tremblay
15:35-16:15 Yogurt and diabetes: evidence from worldwide cohorts Frank Hu
16:15-16:30 Discussion on mechanisms of action André Marette
16:30-16:40 Question and answer period  

Visitez nos réseaux sociaux

Dates importantes

Ouverture de la soumission des résumés
7 janvier 2015
Date limite de soumission des résumés
29 mars 2015 31 mai 2015
Avis d'acceptation
21 avril 2015
Ouverture de l'inscription
7 janvier 2015
Date d’inscription pour les présentateurs
31 mai 2015
Préinscription
31 mai 2015

Infolettre